Serina Therapeutics, Inc.
SER· NYSE
Released May 14, 2024, after the close
10-Q filed May 14, 2024, 44 days after period end · 0001493152-24-019248
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $5.00K | $30.00K | $5.00K | $56.00K |
| Net Income | -$15.02M | $1.66M | -$2.71M | -$2.09M |
| EPS Diluted |
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR
| -$5.38 |
| $0.20 |
| — |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.